Regeneron Pharmaceuticals Unusual Options Activity
Portfolio Pulse from Benzinga Insights
A significant amount of unusual options activity has been observed for Regeneron Pharmaceuticals (NASDAQ:REGN), with a predominantly bearish stance. Of the detected trades, 80% were bearish and 20% bullish. The total amount for puts was $346,389 and for calls was $261,957. Whales have been targeting a price range from $770.0 to $835.0 for REGN over the last 3 months. The current price of REGN is up 1.52% at $791.76. Morgan Stanley, Cantor Fitzgerald, and RBC Capital have maintained their ratings on REGN with price targets of $915, $850, and $847 respectively.

November 01, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Regeneron Pharmaceuticals has seen unusual options activity with a predominantly bearish stance. The current price of REGN is up 1.52% at $791.76. Analysts from Morgan Stanley, Cantor Fitzgerald, and RBC Capital have maintained their ratings with price targets of $915, $850, and $847 respectively.
The unusual options activity, predominantly bearish, indicates that investors are expecting the price of REGN to decrease. This, combined with the fact that the current price is already close to the lower end of the targeted price range by whales, suggests a potential downward pressure on the stock. However, the maintained ratings and price targets by analysts indicate a positive long-term outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100